EGFR and lung adenocarcinoma: Further analysis of mutation sites showed that EGFR-19-Del (22.95%, 56/244) and EGFR-21-L858R (20.49%, 50/244) were the main types of EGFR mutations in patients with lung adenocarcinoma in Zunyi.